Geographical representativeness of published and ongoing randomized controlled trials. the example of: Tobacco consumption and HIV infection

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Ahmad, Nizar ^a,b,c   Boutron, Isabelle ^a,b,c   Dechartres, Agnes ^a,b,c   Durieux, Pierre ^c,d   Ravaud, Philippe ^a,b,c,d  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL AMERICA; EASTERN EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INFECTION PREVENTION; MIDDLE EAST; MORTALITY; NORTH AFRICA; PUBLIC HEALTH PROBLEM; SMOKING CESSATION; SMOKING HABIT; SOUTH ASIA; SYSTEMATIC REVIEW; COST OF ILLNESS; ECONOMICS; GEOGRAPHY; POLICY; PUBLIC HEALTH; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH; SMOKING; STATISTICS;

NICOTIANA TABACUM;

COST OF ILLNESS; GEOGRAPHY; HIV INFECTIONS; HUMANS; PUBLIC HEALTH; PUBLIC POLICY; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH; SMOKING;

EID: 79951802533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016878     Document Type: Article

References (39)

1. ONU (2005) Population Division: World population prospects, the 2004 revision. New York United Nations, Department of Economic and Social Affairs.
2. McDevitt TM, (1999) World population profile. Report WP/98. US Census Bureau website (accessed 2009)http://www.census.gov/ipc/www/wp98.html.
3. Harris E, Tanner M, (2000) Health technology transfer. Bmj 321: 817-820.
4. McMichael C, Waters E, Volmink J, (2005) Evidence-based public health: what does it offer developing countries? J Public Health (Oxf) 27: 215-221.
5. Oxman AD, Bjorndal A, Becerra-Posada F, Gibson M, Block MA, et al. (2010) A framework for mandatory impact evaluation to ensure well informed public policy decisions. Lancet 375: 427-431.
6. Piot P, Bartos M, Larson H, Zewdie D, Mane P, (2008) Coming to terms with complexity: a call to action for HIV prevention. Lancet 372: 845-859.
7. Barreto ML, (2009) Health research in developing countries. Bmj 339: b4846.
8. Say L, Raine R, (2007) A systematic review of inequalities in the use of maternal health care in developing countries: examining the scale of the problem and the importance of context. Bull World Health Organ 85: 812-819.
9. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
10. World Bank Country Classification. World Bank website (accessed 2009)http://www.iqla.org/joining/World-Bank_Classification-List_2009.pdf.
11. International Clinical Trials Registry Platform (ICTRP) World Health Organization website (accessed 2009) http://www.who.int/ictrp/network/primary/en/index.html.
12. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al. (2006) Disease Control Priorities in Developing Countries; Second, editor: A copublication of The World Bank and Oxford University Press.
13. AIDS epidemic update: December 2007. United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization. UNAIDS website (accessed 2009)http://data.unaids.org/pub/epislides/2007/2007_epiupdate_en.pdf.
14. Report on the Global HIV/AIDS Epidemic. UNAIDS website (accessed 2009)http://data.unaids.org/pub/GlobalReport/2008/JC1511_GR08_ExecutiveSummary_en.pdf.
15. WHO, (2008) The global burden of disease: 2004 update. Geneva.
16. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, (2006) Global Burden of Disease and Risk Factors: A copublication of Oxford University Press and The World Bank.
17. Michael T, Gastner MEJN, (2004) Diffusion-based method for producing density-equalizing maps. Proc Nat Acad Sci USA pp. 7499-7504.
18. World Health Statistics Report. World Health Organization website (accessed 2009)http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf.
19. Perel P, Miranda JJ, Ortiz Z, Casas JP, (2008) Relation between the global burden of disease and randomized clinical trials conducted in Latin America published in the five leading medical journals. PLoS ONE 3: e1696.
20. Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, et al. (2004) Relation between randomized controlled trials published in leading general medical journals and the global burden of disease. Cmaj 170: 1673-1677.
21. Swingler GH, Volmink J, Ioannidis JP, (2003) Number of published systematic reviews and global burden of disease: database analysis. Bmj 327: 1083-1084.
22. Sheriff RJ, Adams CE, Tharyan P, Jayaram M, Duley L, (2008) Randomised trials relevant to mental health conducted in low and middle-income countries: a survey. BMC Psychiatry 8: 69.
23. Yusuf S, (2002) Clinical research and trials in developing countries. Stat Med 21: 2859-2867.
24. Louis J. Currat, Andrés de Francisco, Nchinda T, The 10/90 report on health research 2001-2002: The Global Forum for Health Research website (accessed 2009)http://www.globalforumhealth.org/Media-Publications/Publications/10-90-Report-on-Health-Research-2001-2002.
25. Horton R, (2003) Medical journals: evidence of bias against the diseases of poverty. Lancet 361: 712-713.
26. Buekens P, Keusch G, Belizan J, Bhutta ZA, (2004) Evidence-based global health. JAMA 291: 2639-2641.
27. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P, (2007) Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 24: CD003510.
28. Siegfried N, Clarke M, Volmink J, (2005) Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. Bmj 331: 742.
29. Chinnock P, Siegfried N, Clarke M, (2005) Is evidence-based medicine relevant to the developing world? PLoS Med 2: e107.
30. Caldwell JC, (1993) Health transition: the cultural, social and behavioural determinants of health in the Third World. Soc Sci Med 36: 125-135.
31. Eisinger F, Geller G, Burke W, Holtzman NA, (1999) Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet 353: 919-920.
32. Daar AS, Nabel EG, Pramming SK, Anderson W, Beaudet A, et al. (2009) The global alliance for chronic diseases. Science 324: 1642.
33. Fryatt R, Mills A, Nordstrom A, (2010) Financing of health systems to achieve the health Millennium Development Goals in low-income countries. Lancet 375: 419-426.
34. Moseley AM, Elkins MR, Herbert RD, Maher CG, Sherrington C, (2009) Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy. J Clin Epidemiol 62: 1021-1030.
35. Jorgensen AW, Hilden J, Gotzsche PC, (2006) Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. Bmj 333: 782.
36. Olsen O, Middleton P, Ezzo J, Gotzsche PC, Hadhazy V, et al. (2001) Quality of Cochrane reviews: assessment of sample from 1998. Bmj 323: 829-832.
37. Shea B, Moher D, Graham I, Pham B, Tugwell P, (2002) A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Eval Health Prof 25: 116-129.
38. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, et al. (2000) Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. Bmj 320: 537-540.
39. Michaud CM, Murray CJ, Bloom BR, (2001) Burden of disease-implications for future research. JAMA 285: 535-539.